Responses

Download PDFPDF
Retrospective mortality cohort study of Italian workers compensated for silicosis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Authors' Reply to Erren et al.
    • Alessandro Marinaccio, Researcher
    • Other Contributors:
      • Alberto Scarselli, Giuseppe Gorini, Elisabetta Chellini, Marina Mastrantonio, Raffaella Uccelli, Pierluigi Altavista, Franco Merlo and Massimo Nesti

    Mortality results in workers compensated for silicosis in Italy by job and disability degree.

    We wish to thank our German colleagues for giving us the opportunity to clear some points of the mortality study of workers compensated for silicosis in Italy [1]. The large number of silicotic compensated workers investigated allowed us to perform specific analyses to reduce cohort heterogeneity. Subcohort has been i...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Mortality results in workers compensated for silicosis in Italy - Facts and possible artefacts
    • Thomas C. Erren, MD MPH
    • Other Contributors:
      • Peter Morfeld, Christine B. Glende, Claus Piekarski

    Mortality results in a large cohort of workers compensated for silicosis in Italy – Facts and possible artefacts

    With interest we read the article by Marinaccio et al. [1]. Their retrospective mortality study of some 14.000 men compensated for silicosis in the Tuscany region would constitute a powerful addition to studies of cancer risks in compensated silicotics worldwide. In particular, some study results could c...

    Show More
    Conflict of Interest:
    None declared.